Keywords: Merck & Co, Isentress, EU approval, HIV

EU approves expanded use of Merck & Co’s Isentress in adult patients with HIV-1 Infection

Article | 16 September 2009

Print This

Merck Sharp & Dohme, a subsidiary of US drug major Merck & Co, has been granted an expanded licence from the European ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in